Contineum Therapeutics, Inc. (CTNM)
9.86
+0.08
(+0.82%)
USD |
NASDAQ |
Nov 13, 16:00
9.885
+0.02
(+0.25%)
After-Hours: 19:59
Contineum Therapeutics Total Liabilities (Quarterly) : 11.57M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 11.57M |
| June 30, 2026 | 10.71M |
| March 31, 2026 | 11.31M |
| December 31, 2025 | 17.39M |
| September 30, 2025 | 10.38M |
| June 30, 2025 | 11.50M |
| March 31, 2025 | 13.50M |
| December 31, 2024 | 14.78M |
| Date | Value |
|---|---|
| September 30, 2024 | 5.806M |
| June 30, 2024 | 3.852M |
| March 31, 2024 | 199.19M |
| December 31, 2023 | 198.32M |
| September 30, 2023 | 200.19M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 143.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 93.70M |
| Fulcrum Therapeutics, Inc. | 8.784M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 256.99M |
| Shareholders Equity (Quarterly) | 245.42M |
| Debt to Equity Ratio | 0.0255 |
| Current Ratio | 31.11 |
| Net Debt Paydown Yield | -0.02% |